ArticleCureus2025
Assessing the Impact of Intravenous and Parenteral Nutrition (IVPN) Network on the Development and Productivity of Pharmacists, Healthcare Providers, and Researchers.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEffective knowledge sharing and professional networking are critical for enhancing healthcare practice. The Intravenous and Parenteral Nutrition (IVPN) Network, originally focused on nutrition support, has expanded into a global platform supporting professional development across multiple disciplines. However, its broader impact on healthcare providers' growth and practice remains underexplored. This study aimed to evaluate the perceived influence of the IVPN Network through four objectives: (1) to assess awareness and usage, (2) to identify training needs, (3) to evaluate its impact on professional development, collaboration, and patient care, and (4) to measure user satisfaction and advocacy.
methodsA cross-sectional, web-based survey was conducted between September 2024 and January 2025 using non-probability snowball sampling. Eligible participants were pharmacists, healthcare providers, and researchers aged ≥18 years who had engaged with IVPN activities within the past two years. The questionnaire, developed from literature and validated by experts (Cronbach's alpha ≥ 0.79), included demographic items and Likert-scale questions across the four study domains. Data were analyzed using SPSS version 26 (IBM Corp., Armonk, NY). Mann-Whitney U tests were used for sex-based comparisons, Pearson correlation for age and performance scores, and Kruskal-Wallis tests for training effects.
resultsA total of 493 healthcare professionals from 39 countries responded, with the majority from the Gulf region. Awareness of the IVPN Network was relatively high, although patterns of engagement varied. Formal or informal training was significantly associated with higher perceived benefits. Participants reported that the network enhanced access to clinical information, communication, and decision-making, and supported professional collaboration. Overall satisfaction was high, with 95.1% indicating they would recommend the platform.
conclusionThe IVPN Network is perceived to support professional development and collaboration among healthcare providers across diverse regions. While findings provide valuable insights into members' experiences, they reflect self-reported perceptions and cannot be interpreted as causal effects due to the cross-sectional design, reliance on subjective data, and absence of control groups. Future research should incorporate longitudinal designs, objective clinical outcome measures, and independent evaluations to confirm and extend these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.